Australian drugmaker F H Faulding has set up a joint venture in the fast-growing Indonesian pharmaceutical market (annual growth rate is said to be 15%) with the local company PT Tempo, a distributor of pharmaceuticals as well as other products such as fast foods (see also Marketletter December 12, 1994. Faulding said the venture marked the first time that Australian distribution technology would be exported.
Faulding's general manager, Clifford Granger, also noted that there was considerable demand from the Indonesian retail pharmacy sector for technology and value-added services. He said that with the introduction of modern distribution practices, suppliers could meet emergency demands and make it possible for regulatory batch tracing and shelf-life monitoring. The firm's chief executive, Edward Tweddell, said the move to establish a strategic presence in the manufacturing and distribution of value-added products in countries like Indonesia is an integral part of the company's future strategy.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze